>
> SYNOPSIS:
> The sponsor provides support for collaborative research proposals
> on drug abuse and drug addiction that take advantage of special
> opportunities that exist outside the United States. Special
> opportunities include access to unusual talent, resources,
> populations, or environmental conditions in other countries that will
> speed scientific discovery. Projects must have relevance to the
> mission of NIDA and where feasible should address NIDA's scientific
> priority areas. While the priorities will change from year to year, in
> FY06 priority areas include: linkages between HIV/AIDS and drug abuse,
> methamphetamine abuse, inhalant abuse, smoking during pregnancy, and
> drugs and driving. This program will use the NIH
> Exploratory/Developmental (R21) grant mechanism.
>
> Deadline(s): 06/16/2007
> 10/16/2007
> 02/16/2008
> 06/16/2008
> 10/16/2008
> 05/07/2007
> 09/07/2007
> 01/07/2008
> 05/07/2008
> 09/07/2008
> 01/07/2009
> Established Date: 01/18/2007
> Follow-Up Date: 11/01/2007
> Review Date: 02/23/2007
>
> Contact: Steven Gust, Ph.D., Director
>
> Address: International Program
> Office of Science Policy and Communication
> 6001 Executive Boulevard, Room 5274, MSC 9581
> Bethesda, MD 20892-0581
> U.S.A.
> E-mail: ipdirector@nida.nih.gov
>
> Program URL: http://grants1.nih.gov/grants
> Tel: 301-443-6480
> Fax: 301-443-9127
> Deadline Ind: Receipt
> Deadline Open: No
> *See Restrictions for further information.
>
> DEADLINE NOTE
> The deadlines for receipt of standard applications under this
> announcement are: February 16, June 16, and October 16 annually. The
> deadlines for receipt of AIDS-related applications are: January 7, May
> 7, and September 7 annually. This program will expire on January 8,
> 2009.
>
> Award Type(s): Demonstration/Evaluation
> Research Grants/R & D
> Collaborative Project
> Projects Outside the U.S.
>
>
> Citizenship/Country of Applying Institution:
> Any/No Restrictions
>
> Locations Tenable: Any/No Restrictions
>
>
> Appl Type(s): Colleges/Universities
> For-Profit
> HBCU
> Hospital
> Indian Tribes/Governing Orgs.
> Laboratory
> Minority Institution/Organization
> Non-Profit
> Organizations--Community/Soc. Serv.
> Organizations--Health/Medical
> Private Institution/Organization
> Public Institution
> Research Institutions/Organizations
> Researcher/Investigator
> School of Medicine
> Small Business
> State/Local Agencies
> Tax-exempt
>
>
> Target Group(s): NONE
> Funding Limit: $275,000 MAXIMUM
> Duration: 2 YEAR(s)
> Indirect Costs: Unspecified
> Cost Sharing: No
> Sponsor Type: Federal
>
>
> Geo. Restricted: NO RESTRICTIONS
>
> CFDA#: 93.279
>
> OBJECTIVES:
> The sponsor The National Institute on Drug Abuse (NIDA) invites
> applications for international collaborative research on drug abuse
> and drug addiction. The International Program extends the Institute
> mission internationally through programs that: take advantage of
> unique opportunities to advance scientific knowledge through research;
> address the global impact of addiction on public health through
> activities that build research capacity internationally; and
> effectively disseminate and share the knowledge gained through
> NIDA-supported research to scientists, treatment providers, and policy
> makers around the world. Activities sponsored and coordinated by the
> International Program include: support of international collaborations
> to conduct research that allow U.S. scientists to take advantage of
> unique research opportunities; development of bilateral and
> multilateral interchanges with other countries and international
> organizations to share research knowledge for mutual benefit;
> administration of fellowships and professional development activities
> for U.S. and non-U.S. addiction researchers; co-sponsorship of
> meetings and symposia with other countries or international
> organizations; and dissemination of NIDA research and International
> Program activities to a broad international audience.
>
> This program announcement is open to researchers in all areas of
> NIDA-supported science, including basic laboratory studies, clinical
> studies, epidemiological studies, community-based studies, and
> services research. The intent of this program is to stimulate
> state-of-the-science collaborative research between investigators from
> domestic U.S. institutions and researchers in other countries. Funds
> are being made available to take advantage of new opportunities to
> establish collaborative relationships with scientists conducting
> research or with a potential to conduct research in other countries as
> well as to support new research projects from established
> collaborators. NIDA is also very interested in establishing
> relationships with science-funding organizations in other countries,
> and so programmatic priority funding will be given to projects that
> are collaboratively funded by an agency of the foreign country.
> Research priority areas have been identified that are international in
> scope, are associated with substantial detrimental health
> consequences, and for which an international collaborative research
> may provide a unique opportunity to expand our knowledge and ability
> to effectively respond. While this call is meant to be very broad and
> inclusive, the following areas of research are current priority areas:
> HIV/AIDS and drug abuse; methamphetamine; inhalant abuse; smoking
> during pregnancy; and drugged driving.
>
>
> ELIGIBILITY
> Eligible applicants are: for-profit or non-profit organizations;
> public/State-controlled institutions of higher education; private
> institutions of higher education; units of State and local
> governments; units of State and local Tribal government;
> Hispanic-serving institutions; Historically Black Colleges and
> Universities (HBCUs); Alaska Native and Native Hawaiian Serving
> Institutions; Tribally Controlled Colleges and Universities (TCCUs);
> Small Business; eligible agencies of the Federal government; domestic
> or foreign institutions/organizations; and faith-based or
> community-based organizations. More than one PD/PI, or multiple
> PDs/PIs, may be designated on the application for projects that
> require a "team science" approach that clearly does not fit the
> single-PD/PI model.
>
> FUNDING
> This program will use the NIH Exploratory/Developmental (R21) grant
> mechanism. Applications submitted in response to this announcement
> must be submitted electronically through Grants.gov, using the SF424
> Research and Related (R&R) forms and SF424 (R&R) Application Guide.
> The total project period for an application submitted in response to
> this funding opportunity may not exceed two years. Direct costs are
> limited to $275,000 over the two years of the R21 award, with no more
> than $200,000 in direct costs allowed in any single year. Because the
> nature and scope of the proposed research will vary from application
> to application, it is anticipated that the size and duration of each
> award will also vary. F&A costs requested by consortium participants
> are not included in the direct cost limitation.
>
> Reference: NIH Guide, Week Ending January 19, 2007. (kww)
>
> KEYWORDS: Addictions
> Drugs/Drug Abuse
> Smoking Behavior
> Substance Abuse
> AIDS
> AIDS--Substance Abuse
> Health/Nutrition Programs--Developing Countries
> Drug Abuse Prevention
> Drug Abuse Treatment
> Substance Abuse Prevention
> Health Planning/Policy
> Epidemiology
> Data Analysis
> HIV Infection
> Behavior and Health
> Grants.gov
> Grants.gov/S2S
>
>
> ******************************
> Program Number: 91461
> Title: International Research Collaboration on Drug Addiction
> (R03)
>
> Sponsor: National Institute on Drug Abuse/NIH/DHHS
>
> SYNOPSIS:
> The sponsor provides support for collaborative research proposals
> on drug abuse and drug addiction that take advantage of special
> opportunities that exist outside the United States. Special
> opportunities include access to unusual talent, resources,
> populations, or environmental conditions in other countries that will
> speed scientific discovery. Projects must have relevance to the
> mission of NIDA and where feasible should address NIDA's scientific
> priority areas. While the priorities will change from year to year, in
> FY06 priority areas include: linkages between HIV/AIDS and drug abuse,
> methamphetamine abuse, inhalant abuse, smoking during pregnancy, and
> drugs and driving. This program will use the NIH Small Research Grant
> (R03) award mechanism.
>
> Deadline(s): 06/16/2007
> 10/16/2007
> 02/16/2008
> 06/16/2008
> 10/16/2008
> 05/07/2007
> 09/07/2007
> 01/07/2008
> 05/07/2008
> 09/07/2008
> 01/07/2009
> Established Date: 01/18/2007
> Follow-Up Date: 11/01/2007
> Review Date: 02/23/2007
>
> Contact: Steven Gust, Ph.D., Director
>
> Address: International Program
> Office of Science Policy and Communication
> 6001 Executive Boulevard, Room 5274, MSC 9581
> Bethesda, MD 20892-0581
> U.S.A.
> E-mail: ipdirector@nida.nih.gov
>
> Program URL: http://grants1.nih.gov/grants
> Tel: 301-443-6480
> Fax: 301-443-9127
> Deadline Ind: Receipt
> Deadline Open: No
> *See Restrictions for further information.
>
> DEADLINE NOTE
> The deadlines for receipt of standard applications under this
> announcement are: February 16, June 16, and October 16 annually. The
> deadlines for receipt of AIDS-related applications are: January 7, May
> 7, and September 7 annually. This program will expire on January 8,
> 2009.
>
> Award Type(s): Research Grants/R & D
>
>
> Citizenship/Country of Applying Institution:
> Any/No Restrictions
>
> Locations Tenable: Any/No Restrictions
>
>
> Appl Type(s): Colleges/Universities
> For-Profit
> HBCU
> Hospital
> Indian Tribes/Governing Orgs.
> Laboratory
> Minority Institution/Organization
> Non-Profit
> Organizations--Community/Soc. Serv.
> Organizations--Health/Medical
> Private Institution/Organization
> Public Institution
> Research Institutions/Organizations
> Researcher/Investigator
> School of Medicine
> Small Business
> State/Local Agencies
> Tax-exempt
>
>
> Target Group(s): NONE
> Funding Limit: $50,000 YEAR
> Duration: 2 YEAR(s)
> Indirect Costs: Unspecified
> Cost Sharing: No
> Sponsor Type: Federal
>
>
> Geo. Restricted: NO RESTRICTIONS
>
> CFDA#: 93.279
>
> OBJECTIVES:
> The sponsor The National Institute on Drug Abuse (NIDA) invites
> applications for international collaborative research on drug abuse
> and drug addiction. The International Program extends the Institute
> mission internationally through programs that: take advantage of
> unique opportunities to advance scientific knowledge through research;
> address the global impact of addiction on public health through
> activities that build research capacity internationally; and
> effectively disseminate and share the knowledge gained through
> NIDA-supported research to scientists, treatment providers, and policy
> makers around the world. Activities sponsored and coordinated by the
> International Program include: support of international collaborations
> to conduct research that allow U.S. scientists to take advantage of
> unique research opportunities; development of bilateral and
> multilateral interchanges with other countries and international
> organizations to share research knowledge for mutual benefit;
> administration of fellowships and professional development activities
> for U.S. and non-U.S. addiction researchers; co-sponsorship of
> meetings and symposia with other countries or international
> organizations; and dissemination of NIDA research and International
> Program activities to a broad international audience.
>
> This program announcement is open to researchers in all areas of
> NIDA-supported science, including basic laboratory studies, clinical
> studies, epidemiological studies, community-based studies, and
> services research. The intent of this program is to stimulate
> state-of-the-science collaborative research between investigators from
> domestic U.S. institutions and researchers in other countries. Funds
> are being made available to take advantage of new opportunities to
> establish collaborative relationships with scientists conducting
> research or with a potential to conduct research in other countries as
> well as to support new research projects from established
> collaborators. NIDA is also very interested in establishing
> relationships with science-funding organizations in other countries,
> and so programmatic priority funding will be given to projects that
> are collaboratively funded by an agency of the foreign country.
> Research priority areas have been identified that are international in
> scope, are associated with substantial detrimental health
> consequences, and for which an international collaborative research
> may provide a unique opportunity to expand our knowledge and ability
> to effectively respond. While this call is meant to be very broad and
> inclusive, the following areas of research are current priority areas:
> HIV/AIDS and drug abuse; methamphetamine; inhalant abuse; smoking
> during pregnancy; and drugged driving.
>
>
> ELIGIBILITY
> Eligible applicants are: for-profit or non-profit organizations;
> public/State-controlled institutions of higher education; private
> institutions of higher education; units of State and local
> governments; units of State and local Tribal government;
> Hispanic-serving institutions; Historically Black Colleges and
> Universities (HBCUs); Alaska Native and Native Hawaiian Serving
> Institutions; Tribally Controlled Colleges and Universities (TCCUs);
> Small Business; eligible agencies of the Federal government; domestic
> or foreign institutions/organizations; and faith-based or
> community-based organizations. More than one PD/PI, or multiple
> PDs/PIs, may be designated on the application for projects that
> require a "team science" approach that clearly does not fit the
> single-PD/PI model.
>
> FUNDING
> This program will use the NIH Small Research Grant (R03) award
> mechanism. Applications submitted in response to this announcement
> must be submitted electronically through Grants.gov, using the SF424
> Research and Related (R&R) forms and SF424 (R&R) Application Guide.
> Applicants may request a project period of up to two years and budget
> for direct costs of up to $50,000 per year. Because the nature and
> scope of the proposed research will vary from application to
> application, it is anticipated that the size and duration of each
> award will also vary. F&A costs requested by consortium participants
> are not included in the direct cost limitation.
>
> Reference: NIH Guide, Week Ending January 19, 2007. (kww)
>
> KEYWORDS: Addictions
> Drugs/Drug Abuse
> Smoking Behavior
> Substance Abuse
> AIDS
> AIDS--Substance Abuse
> Health/Nutrition Programs--Developing Countries
> Drug Abuse Prevention
> Drug Abuse Treatment
> Substance Abuse Prevention
> Health Planning/Policy
> Epidemiology
> Data Analysis
> HIV Infection
> Behavior and Health
> Grants.gov
> Grants.gov/S2S
>
